| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/04/2007 | CN1989963A Pharmaceutical compositions |
| 07/04/2007 | CN1323719C Remedy for glaucoma comprising Rho kinase inhibitor and beta-blocker |
| 07/04/2007 | CN1323716C Use of SAPR-1 for the treatment and/or prevention of scleroderma |
| 07/04/2007 | CN1323713C Novel usage of soluble P-lectin and anthrax lethal toxin |
| 07/04/2007 | CN1323660C Medicament for the treatment of viral skin and tumour diseases |
| 07/04/2007 | CN1323654C Cosmetic and/or dermatological use of a composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of maleic anhydride |
| 07/03/2007 | US7238813 Antiproliferative agents; angiogenesis factor; wound healing agents; antiischemic agents; anticholesterol agents; antitumor, anticancer agents |
| 07/03/2007 | US7238809 Process for the preparation of inhibitors of macrophage migration inhibitory factor |
| 07/03/2007 | US7238795 Nucleic acid binding compounds containing pyrazolo[3,4-d]pyrimidine analogues of purin-2,6-diamine and their uses |
| 07/03/2007 | US7238718 Method for treating myolytic disease and method for screening antimyolytic agent |
| 07/03/2007 | US7238684 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 07/03/2007 | US7238670 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 07/03/2007 | US7238666 Method of inhibiting fibrosis with a somatostatin agonist |
| 07/03/2007 | US7238664 Intratracheal or intrabronchial administration of Lusupultide and Sildenafil for treatment of COPD, bronchitis, bronchial asthma, pulmonary fibroses, emphysema, interstitial pulmonary disorders, pneumonia, ALI, ARDS and asthma bronchiale |
| 07/03/2007 | US7238525 Inhibition of Bcr-Abl oncoprotein expression in cytoplasm by inducing translocation to the nucleus to activate the apoptotic pathway in cancer cells |
| 07/03/2007 | US7238489 Identification of sortase gene |
| 07/03/2007 | US7238368 Releasable linkage and compositions containing same |
| 07/03/2007 | US7238367 Liposome loading with metal ions |
| 07/03/2007 | US7238360 Getting the same result as gene therapy, without the introduction of exogenous DNA, by binding T cell with immunomodulator biotin, then contacting with avidin or streptavidin; apoptosis induction or resistance |
| 07/03/2007 | CA2447510C Fluorocarbon aerosol medicaments |
| 07/03/2007 | CA2416901C Pharmaceutical compositions comprising a lipase inhibitor and a bile acid sequestrant and their use in the prevention and treatment of obesity |
| 07/03/2007 | CA2416900C The use of a combination of a lipase inhibitor and a pharmaceutically acceptable bile acid sequestrant for the prevention and treatment of diseases associated with high plasma cholesterol levels |
| 07/03/2007 | CA2382548C Treatment of migraine by the administration of alpha-lipoic acid or derivatives thereof |
| 07/03/2007 | CA2156162C Cancer treatment |
| 06/28/2007 | WO2007072980A1 Novel application of apelin |
| 06/28/2007 | WO2007072977A1 Pharmaceutical composition for allergic disease |
| 06/28/2007 | WO2007072645A1 Method of regulating cell size and/or cell cycle |
| 06/28/2007 | WO2007072564A1 Remedy/preventive for heart failure |
| 06/28/2007 | WO2007072503A2 Combinations for managing inflammation and associated disorders |
| 06/28/2007 | WO2007072169A2 Pharmaceutical combination for the treatment of luts comprising a pde5 inhibitor and a muscarinic antagonist |
| 06/28/2007 | WO2007072156A1 Pharmaceutical combination of a pde-5 inhibitor and a 5-alpha reductase inhibitor |
| 06/28/2007 | WO2007071721A2 Ginger extract for inhibiting human drug transporters |
| 06/28/2007 | WO2007071708A2 Ginger fraction for inhibiting human cyp enzymes |
| 06/28/2007 | WO2007071313A2 Combination of anticholinergics, glucocorticoids, beta2-ag0nists, pde4 inhibitor and antileukotriene for the treatment of inflammatory diseases |
| 06/28/2007 | WO2007038551A3 Use of ibudilast for treating drug and behavioral addictions |
| 06/28/2007 | WO2007014943A3 Therapy for neurological diseases |
| 06/28/2007 | WO2007014029A3 Yin yang 1 as a treatment for cardiac hypertrophy and heart failure |
| 06/28/2007 | WO2006060507A9 Compositions comprising immunomodulatory compounds and the use thereof for the treatment of immunodeficiency disorders |
| 06/28/2007 | WO2005113601A8 Antibodies and molecules derived therefrom that bind to steap-1 proteins |
| 06/28/2007 | WO2005054437A3 Compositions and methods for ex vivo preservation of blood vessels for vascular grafts using inhibitor of type i and/or type ii phosphodiesterases |
| 06/28/2007 | WO2005027839A3 Methods and reagents for the treatment of immunoinflammatory disorders |
| 06/28/2007 | US20070149769 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs) |
| 06/28/2007 | US20070149587 Valsartan Salts |
| 06/28/2007 | US20070149578 Combination Therapy |
| 06/28/2007 | US20070149571 Combination therapy for treating or managing acute myelocytic leukemia |
| 06/28/2007 | US20070149555 Prophylatic and/or therapeutic agents for chronic musculoskeletal pain |
| 06/28/2007 | US20070149539 Use of c-src inhibitors alone or in combination with sti571 for the treatment of leukaemia |
| 06/28/2007 | US20070149498 Cancer therapy |
| 06/28/2007 | US20070149496 Water-soluble compound |
| 06/28/2007 | US20070149492 Method of affecting sleep and sleep-related behaviors |
| 06/28/2007 | US20070149476 Combination Comprising Combretastatin and Anticancer Agents |
| 06/28/2007 | US20070149451 For example, vildagliptin and orlistat or phentermine |
| 06/28/2007 | US20070148688 Novel human enzymes of the metalloprotease family |
| 06/28/2007 | US20070148261 Cancer treatment method |
| 06/28/2007 | US20070148256 Pharmacologic-functioning water and usage of the same |
| 06/28/2007 | US20070148255 Compositions for delivery of drug combinations |
| 06/28/2007 | US20070148236 Pharmaceutical Compositions of Adsorbates of Amorphous Drug |
| 06/28/2007 | US20070148216 External preparation for percutaneous administration containing nonsteroidal anti-inflammatory analgesic |
| 06/28/2007 | US20070148178 Using beacizumab and antitumor agent as therapeutic treatment for mesothelioma |
| 06/28/2007 | US20070148177 Treatment with anti-vegf antibodies |
| 06/28/2007 | US20070148173 Treatment of Acute Lung Injury, Fibrosis and Metastasis with Antagonists of Alpha V Beta 6 |
| 06/28/2007 | US20070148169 Therapeutic agent for chronic arthritides diseases of childhood-related diseases |
| 06/28/2007 | US20070148125 Coordination complex of diaminocyclohexaneplatinum(II) with block copolymer containing poly(carboxylic acid) segment and antitumor agent comprising the same |
| 06/28/2007 | US20070148088 Cytotoxic therapy |
| 06/28/2007 | DE20122735U1 Verwendung einer Zubereitung für Restenoseprophylaxe Use of a composition for prophylaxis of restenosis |
| 06/28/2007 | CA2634363A1 Novel application of apelin |
| 06/28/2007 | CA2634019A1 Pharmaceutical combination for the treatment of luts comprising a pde5 inhibitor and a muscarinic antagonist |
| 06/28/2007 | CA2633570A1 Pharmaceutical combination of a pde-5 inhibitor and a 5-alpha reductase inhibitor |
| 06/28/2007 | CA2632908A1 Ginger extract for inhibiting human drug transporters |
| 06/28/2007 | CA2632780A1 Combination of r,r-glycopyrrolate, rolipram, and budesonide for the treatment of inflammatory diseases |
| 06/28/2007 | CA2631823A1 Ginger fraction for inhibiting human cyp enzymes |
| 06/27/2007 | EP1801218A2 Nucleic acids and proteins from streptococcus pneumoniae |
| 06/27/2007 | EP1800691A2 Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer |
| 06/27/2007 | EP1800680A1 Cerebral infarction suppressant |
| 06/27/2007 | EP1800678A1 Combination of an inhibitor of the If current of the sinus node and an inhibitor of the angiotensin converting enzyme |
| 06/27/2007 | EP1800672A1 Pharmaceutical composition and the use therof for the treatment of dermatoses |
| 06/27/2007 | EP1800666A1 Nanoparticulate compositions of angiogenesis inhibitors |
| 06/27/2007 | EP1799686A1 Bioreductively-activated prodrugs |
| 06/27/2007 | EP1799682A2 Reversible inhibitors of s-adenosyl-l-homocysteine hydrolase and uses thereof |
| 06/27/2007 | EP1799264A2 Methods and compositions for treating migraine pain |
| 06/27/2007 | EP1799263A2 Reducing er stress in the treatment of obesity and diabetes |
| 06/27/2007 | EP1799205A1 Medicaments for inhalation comprising pde iv inhibitors and enantiomercally pure glycopyrrolate salts |
| 06/27/2007 | EP1799204A1 Composition containing omega-3 fatty acids and omega-6 fatty acids |
| 06/27/2007 | EP1539181B1 Method of treating lower urinary tract disorders |
| 06/27/2007 | EP1504004B1 Substituted pyrazolopyrimidines |
| 06/27/2007 | EP1490034B1 Novel pharmaceutical compositions for antihistaminic-decongestant combination and method of making such compositions |
| 06/27/2007 | EP1471874A4 Compositions and delivery methods for the treatment of wrinkles, fine lines and hyperhidrosis |
| 06/27/2007 | EP1392259B1 Delivery of erectile dysfunction drugs through an inhalation route |
| 06/27/2007 | EP1374898B1 Use of interleukin-12 for treating nerve damage |
| 06/27/2007 | EP1305419B1 Modulation by il-tif/interleukin-21 |
| 06/27/2007 | EP1107986B1 Protein domains in the hepatic glycogen-targeting subunit of protein phosphatase 1 and methods of making and using the same |
| 06/27/2007 | EP1061913B1 The use of a protein tyrosine inhibitor such as genistein in the treatment of diabetic retinopathy |
| 06/27/2007 | EP0954340B1 Targeted combination immunotherapy of cancer |
| 06/27/2007 | CN1989439A Methods and compositions for the treatment of uveitis |
| 06/27/2007 | CN1988885A Pharmaceutical compositions |
| 06/27/2007 | CN1985993A Compound preparation for enhancing memory |
| 06/27/2007 | CN1322897C Use of IL-18 inhibitors |
| 06/26/2007 | US7235690 Anthranilamides and methods of their use |
| 06/26/2007 | US7235689 Hydroxamic acid derivatives having anti-inflammatory action |
| 06/26/2007 | US7235664 Potassium channel modulators; antiarrhythmia agents |